SANOFICONR
NSEPrice History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Trend
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹180.7 Cr | ₹172.6 Cr | ₹220.9 Cr | ₹233.9 Cr |
| Net Profit | ₹44.3 Cr | ₹50 Cr | ₹60.7 Cr | ₹62.9 Cr |
| EPS | — | ₹21.69 | ₹26.36 | ₹27.31 |
| Operating Profit | ₹64.3 Cr | ₹69.2 Cr | ₹82.4 Cr | ₹88 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Sanofi Consumer Healthcare India Limited | ₹4,566.70 | +1.34% | 40.2 | ₹10.52K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Jun 2026 | Dividend - Rs 75 Per Share | DIVIDEND |
| 17 Apr 2025 | Dividend - Rs 55 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SANOFICONR
View All
FMCG, healthcare in line for strong show in FY27: Brickworks
India's consumer goods and healthcare sectors are poised for robust growth this fiscal year, driven by tax relief, increasing consumer spending, and a booming medical tourism industry. Brickwork Ratings anticipates a significant revenue jump for consumer goods, while healthcare benefits from strong financial health and government initiatives. Most sectors show a stable outlook, with power distribution being the sole exception due to persistent debt issues.
India's IPO pipeline in the second half may touch $40 billion as billion-dollar listings line up: JPMorgan
Abhinav Bharti, Managing Director and Head of India ECM at JPMorgan said the Indian market has sufficient depth to absorb multiple large IPOs simultaneously, while global investor interest remains strong for sizeable IPOs across consumer, consumer tech and healthcare sectors.
Depth over breadth: Piramal Consumer Healthcare takes a leaf out of the modern FMCG playbook
The company is cutting new product launches by half and doubling down on quick commerce to chase a $200 million revenue target by 2030, CEO Sai Ramana Ponugoti told Mint.